Cost-efficient care Empo Health targets diabetic foot ulcers with at-home imaging and remote monitoring to enable early detection and intervention, appealing to payors and clinics seeking cost reductions from fewer advanced treatments and amputations.

Care coordination The combination of patient-facing imaging (Empo Footprint) and clinician-facing monitoring (Empo Remote Health Link) creates an integrated workflow that can be sold to podiatrists, endocrinologists, and home health providers seeking seamless remote care.

High-risk market With DFUs affecting a large portion of diabetic patients and substantial US spend, there is a sizable addressable market for preventive monitoring solutions, especially in Medicare/Medicaid and employer-based health plans.

Regulatory proof FDA-listed footprint device provides regulatory credibility; sales motions can emphasize compliance and reimbursement readiness to clinics and hospital systems seeking validated technology.

Growth prerequisites Small team size suggests we should target partnerships and channel sales with established distributors, integrators, or telehealth platforms to scale adoption without extensive internal headcount.